Virus-removing filter

Abstract: A virus-removing filter using, as a virus-capturing body, at least one of a sialic acid, a sialic acid derivative, and sugars, glycoproteins and glycolipids containing sialic acid and/or a sialic acid derivative.

Description: Background of the Invention The present invention relates to an air filter for removing viruses, such as influenza, viruses, suspended in air. As a means for removing the virus suspended in the air, a technique 'to capture the virus with a filter and inactivate the thus captured virus with ultraviolet light has been conventionally known. However, since the ultraviolet light Is harmful to human bodies, it is difficult to use such a technique in ordinary living spaces. In addition, the ultraviolet light is likely to deteriorate the material of the filter and accompanying equipment. Further, although gauze masks are widely used in the ordinary living spaces, such gauze masks cannot capture the viruses. In view of the disclosure below, it is mentioned that US-A-4355102 discloses use of sialic acid in a test system for detecting influenza viruses. Summary of the invention The present invention seeks to overcome the above-mentioned problem, and has been accomplished to provide virus-removing filters which can be used in the ordinary living space and effectively remove viruses such as influenza. The present invention provides an air filter having, as a virus-capturing component in the filter at least one compound selected from a sialic acid, a sialic acid derivative, and sugars, glycoproteins and glycolipids containing a sialic acid and/or a sialic acid derivative. Sialic acids are N- and O-acyl derivatives of neuraminic acid. Preferably the component is impregnated or kneaded in a substrate, e.g. a gauze. The filter may comprise a body of material with which the component is covalently bonded. The filter may comprise a body of polymerized/copolymerized material which is obtained by polymerizing and/or copolymerizing styrene monomer and/or acryl amide monomer into which the component is incorporated. Any other suitable polymerizable monomer may be employed in the same way. These and other optional features and advantages of the invention will be appreciated upon reading of the following detailed description of the invention when taken in conjunction with the attached drawings. Brief Description of the Invention Reference is made to the attached drawings, wherein: Fig. 1 shows chemical structures of some sialic acid derivatives present in nature; Fig. 2 shows chemical reaction formulae for the steps of producing a composite glucoside polymeric material containing sialic acid; and Fig. 3 shows a separated and extracted component type 1-a sugar chain (a sugar containing sialic acid). Detailed Description of the Invention In the following, embodiments of the present invention will be explained In more detail. (1) In the present invention, at least one kind of sialic acid, a sialic acid derivative, and sugars, glycoproteins and glycolipids containing sialic acid and/or the sialic acid derivative, their covalently bonded materials and/or the polymers or copolymers containing them is used as a constituent element for capturing the viruses. Sialic acid is contained in various living thing, and exists in the state that it usually constitutes cell surface layer glycolipids and is bonded to glycoside-bonded to terminals of glycoproteins or glycolipids (composite glucides). Sialic acid used in the present invention can be economically produced by a process described in NGK's Japanese patent application Laid-open No. 6-263,80-1. According to this process, sialic acid is released by hydrolyzing colominic acid produced by bacteria such as Escherichia coli with an acid. On the other hand, many viruses such as influenza to be captured by the present invention have proteins called "hemagglutinin" at their surfaces. It is known known that as this 'hemagglutinin bonds to sialic acid at surfaces of cells of an animal, the animal is infected with such viruses. That is, these viruses function to infect the cells via sialic acid as receptor at the cell surface of the animal. The present invention utilizes the above phenomenon, and is to remove the virus having the "hemagglutinin" by capturing the virus with sialic acid, its derivative or the like as or in a virus-capturing body which has been incorporated into a filter. Any sialic acid or derivative effective to capture viruses may be employed.As the sialic acid derivative, a deoxy form and a dehydroxy form of sialic acid may be recited. In Fig. 1 is shown some of such sialic acid derivatives occurring in nature. As sugars containing sialic acid or its derivatives, sialyl lactose and sialyl lactosamine may be recited. As glycoproteins containing sialic acid or a sialic acid derivative, for example, mucin may be recited. As glycolipids containing sialic acid or its derivatives, for example, ganguliosid may be recited. The above-recited materials may be used singly or in combination as or in the virus-capturing body for capturing the viruses having "hemagglutinin". Any such material effective to capture viruses may be employed. (2) A substrate in which at least one kind of sialic acid, a sialic acid derivative, sugars, glycoproteins, or glycolipids containing sialic acid and/or the sialic acid derivative is impregnated or kneaded may be also used as a virus-capturing body. If a gauze is used as the substrate, it may be used as a virus-removing mask. (3) A material with which at least one kind of sialic acid, a sialic acid derivative, sugars, glycoproteins, or glycolipids containing sialic acid and/or the sialic acid derivative is covalently bonded may be used as a virus-capturing body. If this covalently bonded material is sandwitched in a gauze, it may be used as a virus-removing mask. In this case, the covalently bonded material in the form of powder is placed in a bag, and this bag sandwiched with a gauze. (4) A polymerized and/or copolymerized material which is obtained by polymerizing and/or copolymerizing styrene monomer and/or acryl amide monomer into which at least one kind of sialic acid, a sialic acid derivative, sugars, glycoproteins, or glycolipids containing sialic acid and/or the sialic acid derivative is incorporated may be used as a virus-capturing body. Fig. 2 shows the steps in the production of the virus-capturing body using the styrene monomer. Sialic acid (1) and p-vinylbenzyl amine (2) are subjected to a condensation reaction, thereby obtaining a sialic acid-substituted styrene monomer (3). This monomer (3) is subjected to a polymerization, thereby obtaining a composite sugar polymer (4). Since sialic acid or the like may be incorporated or bonded to a synthetic resin according to this process, the resulting synthetic resin may be used as a virus-removing filter or a virus-removing mask as it is or in the state that such a synthetic resin is sandwiched with a gauze. If the synthetic resin is used as it is, the resin may be used in a porous form. If the synthetic resin is used in the state that it is sandwiched with a gauze, the resin in the form of powder is, for example, placed in a bag, and this bag is sandwiched with the gauze. (Example 1) Streptococcus agalactiae (hereinafter referred to as "B-group Streptococcus") type la was cultivated in a Todd-Hewitt broth containing 2% glucose and 1.5% disodium hydrogenphosphate and buffered at pH 7.0 to 7.2. A component of the type1-a sugar chain (sugar containing sialic acid) shown in Fig. 3 was separated and extracted from the resulting culture, and was dissolved into pure water, thereby preparing a 1% aqueous solution. A conventional filter (a commercially available gauze mask) was immersed in this aqueous solution, lightly dewatered, and dried to attached the extracted component thereon. Thus, the filter with the sugar containing sialic acid (hereinafter referred to as "sialic acid-containing filter 1") was obtained. Virus-removing tests were conducted by using the sialic acid-containing filter 1 and a conventional filter. The test was conducted as follows. That is, a suspended liquid was prepared by suspending A type influenza virus A/PR/8/34 (H1N1) strain in physiologic saline (0.9% aqueous solution of sodium chloride). Then, the suspended liquid was passed through each of filters, and a titer of the liquid passed was measured. The titer was measured by utilizing a phenomenon that if influenza virus attached to red blood cells, the cells cause aggregation. That is, 2-fold diluted, 4-fold diluted, 8-fold diluted, ··· aqueous solutions were prepared by diluting the suspended liquid having passed the filter with physiologic saline.A given amount of each of the thus diluted aqueous solutions was successively mixed with the same amount of a 0.4% suspended liquid of fowl red blood cells, and the titer was obtained by determining that with up to which fold diluted solution the fowl red blood cell aqueous solution caused aggregation reaction. Results are shown in the following Table 1. In this table, blank shows a titer of a raw liquid (the virus-suspended liquid before dilution). Kind of filter Titer Blank 512 Conventional filter (one sheet) 512 Conventional filter (two sheets) 512 Sialic acid-containing filter 1 (one sheet) 16 Sialic acid-containing filter 1) two sheets) 4 As is clear from the data shown in Table 1, the titer of the liquid having passed the conventional filter was the same as that of the raw liquid, and the conventional filter has completely no virus-removing effect. To the contrary, the titers of the liquid having passed the filter according to the present invention were reduced to 1/32 to 1/128 of that of the raw liquid, which means that most of the virus was removed. (Example 2) "B-group Streptococcus") type III was cultivated in the same manner as in Example 1. A component of the III type sugar chain (sugar containing sialic acid) shown in Fig. 3 was separated and extracted, and was dissolved into pure water from the resulting culture, thereby preparing a 1% aqueous solution. A conventional filter was immersed in this aqueous solution, lightly dewatered, and dried to attach the extracted component thereon. Thus, the filter with the sugar containing sialic acid (hereinafter referred to as "sialic acid-containing filter 2") was obtained. Virus-removing tests were conducted by using the sialic acid-containing filter 2 and a conventional filter. The test was conducted as follows. That is, a suspended liquid was prepared by suspending type A influenza virus A/Aichi/2/68 (H3N2) strain in physiologic saline. Then, the suspended liquid was passed through each of filters, and a titer of the liquid passed was measured in the same manner as in Example 1. Results are shown in the following Table 2. In this table, blank shows a titer of a raw liquid (the virus-suspended liquid before dilution). Kind of filter Titer Blank 1024 Conventional filter (one sheet) 1024 Conventional filter (two sheets) 1024 Sialic acid-containing filter 1 (one sheet) 32 Sialic acid-containing filter 1) two sheets) 4 As is clear from the data shown in Table 2, the titer of the liquid having passed the conventional filter was the same as that of the raw liquid, and the conventional fitler has completely no virus-removing effect. To the contrary, the titers of the liquid having passed the filter according to the present invention were reduced to 1/32 to 1/256 of that of the raw liquid, which means that most of the virus was removed. (Example 3) The 1 % aqueous solutions of the extracted component of the sialic acid sugar chain prepared in each of Examples 1 and 2 were mixed at a 50:50 ratio. A conventional filter was immersed into the resulting mixed solution, lightly dewatered and then dried, thereby attaching the extracted component upon the filter. Thus, the filter with the sugar containing sialic acid (hereinafter referred to as "sialic acid-containing filter 3) was obtained. Virus-removing tests were conducted by using the sialic acid-containing filter 3 and a conventional filter. The test was conducted as follows. That is, a suspended liquid was prepared by suspending type A influenza virus A/PR/8/34 (H1N1) strain in physiologic saline. Then, the suspended liquid was passed through each of filters, and a titer of the liquid passed was measured in the same manner as in Examples 1 and 2. Results are shown in the following Table 3. In this table, blank shows a titer of a raw liquid (the virus-suspended liquid before dilution). Kind of filter Titer Blank 512 Conventional filter (one sheet) 512 Conventional filter (two sheets) 512 Sialic acid-containing filter 1 (one sheet) 32 Sialic acid-containing filter 1) two sheets) 8 As is clear from the data shown in Table 3, the titer of the liquid having passed the conventional filter was the same as that of the raw liquid, and the conventional filter has completely no virus-removing effect. To the contrary, the titers of the liquid having passed the filter according to the present invention were reduced to 1/16 to 1/64 of that of the raw liquid, which means that most of the virus was removed. (Example 4) Virus-removing tests were conducted by using the sialic acid-containing filter 3 obtained in Example 3 and a conventional filter. The test was conducted as follows. That is, a suspended liquid was prepared by suspending type A influenza virus A/Aichi/2/68/ (H3N2) strain in physiologic saline. Then, the suspended liquid was passed through the same manner as in Examples 1, 2 and 3. Results are shown in the following Table 4. In this table blank shows a titer of the raw liquid (the virus-suspended liquid before dilution). Kind of filter Titer Blank 1024 Conventional filter (one sheet) 1024 Conventional filter (two sheets) 1024 Sialic acid-containing filter 1 (one sheet) 64 Sialic acid-containing filter 1) two sheets) 8 As is clear from the data shown in Table 4, the titer of the liquid having passed the conventional filter was the same as that of the raw liquid, and the conventional filter has completely no virus-removing effect. To the contrary, the titers of the liquid having passed the filter according to the present invention were reduced to 1/16 to 1/64 of that of the raw liquid, which means that most of the virus was removed. In each of Examples 1 to 4, the tests were effected in the state that the virus was suspended in the physiologic saline. Since a similar effect can be expected with respect to the virus suspended in air, the filter according to the present invention can be used as a virus-removing mask as it is.

Claims: An air filter for removing viruses suspended in air, having as a virus-capturing component in the filter, at least one component selected from a sialic acid, a sialic acid derivative, and sugars, glycoproteins and glycolipids containing a sialic acid and/or a sialic acid derivative. A filter according to claim 1, wherein said virus-capturing component is impregnated or kneaded in a substrate. A filter according to claim 2, wherein said substrate is a gauze. A filter according to claim 1, comprising a body of material with which said at least one component is covalently bonded. A filter according to claim 4, wherein said body of material is sandwiched in a gauze. A filter according to claim 1, comprising a body of polymerized/copolymerized material which is obtained by polymerizing and/or copolymerizing styrene monomer and/or acrylic amide monomer into which said at least one component is incorporated. A filter according to claim 6, wherein said body of polymerized/copolymerized material is sandwiched in a gauze. A filter according to any one of claims 1 to 7 wherein said component is a sialic acid derivative which is a deoxy form of sialic acid or a dehydroxy form of sialic acid. A mask having an air filter according to any one of claims 3, 5, 6 and 7.

Inventors: KAWASE MITSUI, KAWASE YUJI, KOBAYASHI KAZUKIYO, SUZUKI YASUO, YAMADA KAZUNARI, KAWASE, MITSUI, KAWASE, YUJI, KOBAYASHI, KAZUKIYO, SUZUKI, YASUO, YAMADA, KAZUNARI
Applicants: NGK INSULATORS LTD, NGK INSULATORS, LTD.
Application year: 1996
Main classification: B01J20
IPC codes: A62B23, C07H5, A61L9, B01D39, B01J20